Serplulimab

Serplulimab
Clinical data
Other namesHLX10, HANSIZHUANG, Zerpidio
Routes of
administration		Intravenous
Drug classAntineoplastic agent
ATC code
Legal status
Legal status
  • CN: Rx-only
Identifiers
CAS Number
DrugBank
UNII
KEGG

Serplulimab is a monoclonal antibody used for the treatment of cancers.[1][2]

  1. ^ Cite error: The named reference Hetronifly EPAR was invoked but never defined (see the help page).
  2. ^ Lee A (July 2022). "Serplulimab: First Approval". Drugs. 82 (10): 1137–1141. doi:10.1007/s40265-022-01740-0. PMID 35796953.